非共价交叉连接凝:一种用于内脏血液静止的新方法
Chenyu Zhao1, Han Wang1, Xue Sun1
1National Institutes for Food and Drug Control, Beijing 100050, China.
Gels (Basel, Switzerland)
|May 24, 2024
概括
一种新的原和酸水凝有效地阻止内脏出血. 这种先进的静血材料提供了更好的强度,附着性和生物降解性,用于更好的伤口愈合和临床应用.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 手术创新 在外科创新.
背景情况:
- 过度的失血可能导致严重的病理状况,包括组织亡,器官衰竭和死亡.
- 目前的静血剂具有诸如机械强度差,对湿组织的粘附性不足以及血静效率不足等局限性,阻碍其用于控制内脏出血的使用.
研究的目的:
- 开发和评估一种基于原和酸 (TA) 的新型水凝,用于有效的内脏血液静止.
- 为了优化水凝的组成,以提高机械性能,粘附和凝固能力.
主要方法:
- 使用原蛋白和酸 (TA) 合成了一种新的水凝 (CT).
- 对原蛋白和TA的比例进行了变化,以优化机械特性,粘附性和凝固能力.
- 在大鼠肝脏和心脏出血模型中评估了水凝的静血性能,并将其与商业水凝进行比较.
主要成果:
- 新型CT水凝在动物模型中显示,与商业水凝相比,血液流失减少,血液静止时间显著缩短.
- 水凝表现出优异的静血特性,并促进伤口在潮湿的环境中关闭.
- TA和原之间的非共价键确保了生物降解性,而不妨碍随后的组织修复.
结论:
- 开发的原酸水凝为内脏血液静止提供了一个有前途的新策略,在治疗急性伤口和控制严重出血方面具有优势.
- 它的简单而高效的生产方法有助于潜在的临床转化.
- 水凝的特性解决了现有的静血方法的局限性,为改善患者治疗结果铺平了道路.
相关概念视频
01:05Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
01:16Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681